Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:13 PM
Ignite Modification Date: 2025-12-24 @ 11:13 PM
NCT ID: NCT02129569
Eligibility Criteria: Inclusion Criteria: * PATIENTS: Within 12 months of a new diagnosis of multiple myeloma or less than or equal to 2 cycles of treatment (all stages, with or without treatment) * PATIENTS: Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 2 * PATIENTS: Ambulatory with or without an assistive device (cane, walker) * PATIENTS: Cognitively intact, as evidenced by orientation to person, place, and time * PATIENTS: Ability to speak, read, and comprehend English * PATIENTS: Has an identified family caregiver who is willing to participate * CAREGIVERS: Any family member, who is identified by the patient as his/her caregiver * CAREGIVERS: ECOG performance status less than or equal to 2 * CAREGIVERS: Ambulatory with or without an assistive device (cane, walker) * CAREGIVERS: Cognitively intact, as evidenced by orientation to person, place, and time * CAREGIVERS: Ability to speak, read, and comprehend English * CAREGIVERS: Has an identified family member who is a patient * CAREGIVERS: Caregivers do not need to reside with the patient Exclusion Criteria: * PATIENTS: Have severe pain (pain score of 7 to 10 on a 0 to 10 scale) * PATIENTS: Are at high risk for bone fracture or who have a new fracture needing intervention, as determined by the physician * PATIENTS: Have untreated venous thrombosis, as determined by the physician * PATIENTS: Have a life expectancy of less than six months, as determined by the physician, and their caregivers * PATIENTS: Receiving active, concurrent treatment for a prior history of cancer (hormonal therapies allowed) * CAREGIVERS: Diagnosis of cancer and received cancer treatment within one year * CAREGIVERS: Medical condition that significantly affects their ability to walk * PATIENT or CAREGIVER: Is hearing impaired to the degree that they are unable to hear instructions via the phone * PATIENTS or CAREGIVER: Lives in a skilled nursing facility
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Study: NCT02129569
Study Brief:
Protocol Section: NCT02129569